摘要 |
<p>Methods are described, which include the administration of semapimod or guanylhydrazone containing compounds, salt thereof, or a combination of the compound and a salt thereof for the inhibition, treatment, and/or prevention of any of NEC, a condition associated with the release of HMGBl, a condition associated with the release of iNOS protein, a condition associated with the release of Bax protein, a condition associated with the release of Bad protein, a condition associated with the release of COX-2 protein, or a condition associated with the release of RAGE, or a combination thereof to a subject in need thereof.</p> |
申请人 |
CYTOKINE PHARMASCIENCES, INC.;ZAMORA, RUBEN;FORD, HENRI, R.;SIELECKI-DZURDZ, THAIS, M.;DE LA CRUZ, VIDAL, F. |
发明人 |
ZAMORA, RUBEN;FORD, HENRI, R.;SIELECKI-DZURDZ, THAIS, M.;DE LA CRUZ, VIDAL, F. |